New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 27, 2014
11:29 EDTCTRX, CVS, ESRXCatamaran plunges after full year profit outlook trails expectations
Shares of Catamaran (CTRX), a provider of pharmacy benefit management services, are sinking after the company's fiscal 2014 profit outlook significantly trailed expectations. WHAT'S NEW: This morning, Catamaran reported fourth quarter earnings per share of 56c and revenue of $4.53B, topping expectations of 54c and $4.04B, respectively. The company forecast FY14 adjusted EPS of $2.04-$2.19, compared to consensus of $2.41. FY14 revenue was guided to $20B-$21B, versus consensus of $20.16B. ANALYST REACTION: This morning, analyst commentary was positive. Research firm Jefferies said weakness in the shares of Catamaran was a buying opportunity. The firm recommended buying the stock on weakness saying Catamaran is likely to sustain its strong top-line growth. Jefferies had a Buy rating on the stock with a $70 price target. Another firm, Leerink, said Catamaran's long-term growth drivers remained intact despite its weaker than expected 2014 outlook. It kept an Outperform rating on the stock. PRICE ACTION: In late morning trading, Catamaran fell $6.03, or about 11.6%, to $45.78 on nearly four times its average daily trading volume. Including today's slide, the stock has lost about 17% over the past twelve months. OTHERS TO WATCH: Other firms that provide pharmacy benefit management services include Express Scripts (ESRX) and CVS Caremark (CVS).
News For CTRX;ESRX;CVS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2015
06:21 EDTCVSSuit alleges CVS overcharged for generic drugs, AP reports
Subscribe for More Information
July 30, 2015
09:08 EDTCVSCVS Health enters into two new clinical affiliations
Subscribe for More Information
06:48 EDTCVSCVS Health announces partnership with IBM Watson
Subscribe for More Information
July 29, 2015
07:45 EDTESRXExpress Scripts appears to be gaining momentum, says RBC Capital
Subscribe for More Information
July 28, 2015
19:10 EDTESRXOn The Fly: After Hours Movers
Subscribe for More Information
16:18 EDTESRXExpress Scripts up 2.6% after reporting Q2 results, guidance
Subscribe for More Information
16:18 EDTESRXExpress Scripts sees FY16 adjusted claims 1.26B-1.3B
Subscribe for More Information
16:17 EDTESRXExpress Scripts sees retention rate for FY15 selling season 95%-97%
Subscribe for More Information
16:15 EDTESRXExpress Scripts reports Q2 adjusted claims down 1% to 321.2M
Subscribe for More Information
16:14 EDTESRXExpress Scripts raises FY15 EPS view to $5.46-$5.54 from $5.37-$5.47
Subscribe for More Information
16:13 EDTESRXExpress Scripts sees Q3 adjusted EPS $1.41-$1.45, consensus $1.43
Subscribe for More Information
16:11 EDTESRXExpress Scripts reports Q2 adjusted EPS $1.44, consensus $1.40
Subscribe for More Information
15:21 EDTESRXNotable companies reporting after market close
Subscribe for More Information
July 22, 2015
05:22 EDTESRXStocks with implied volatility movement; LOCK ESRX
Subscribe for More Information
July 21, 2015
12:39 EDTESRXCiti analyzes a potential Express Scripts takeout by Walgreens Boots Alliance
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use